Chronic myelogenous leukemia
What is chronic myelogenous leukemia?
Chronic myelogenous leukemia (CML) is a type of leukemia that develops slowly. Learn about symptoms, diagnosis, treatment and risks in our guide to CML.
Risk factors for chronic myelogenous leukemia (CML)
Risk factors for chronic myelogenous leukemia (CML) include high doses of radiation and exposure to formaldehyde. Learn about CML risk.
Staging of chronic myelogenous leukemia
Chronic myelogenous leukemia is not staged but is given a phase based on blood cell counts and symptoms. Learn about the phases of CML.
Disease progression of chronic myelogenous leukemia
Chronic myelogenous leukemia usually progresses slowly. Learn about where CML spreads and how CML progresses.
Prognosis and survival for chronic myelogenous leukemia
Prognostic factors for chronic myelogenous leukemia include your age and the phase of the cancer. Learn about prognosis and survival for CML.
Treatments for chronic myelogenous leukemia
Treatments for chronic myelogenous leukemia (CML) include targeted therapy and stem cell transplant. Learn about treatment plans and options for CML.
Supportive care for leukemia
Supportive care helps people with physical and emotional aspects of leukemia. Learn how to cope with long-term effects of leukemia.
Research in chronic myelogenous leukemia (CML)
We are always learning more about cancer. Researchers and healthcare professionals use what they learn from research studies to develop better practices that will help prevent, find and treat chronic myelogenous leukemia (CML). They are also looking for ways to improve the quality of life of people with CML.
Chronic myelogenous leukemia statistics
Chronic myelogenous leukemia (CML) is the 3rd most common type of leukemia diagnosed in adults in Canada. Learn about statistics for this cancer.